This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Andreassen, A. Articles by Fodstad, O. Search for Related Content PubMed PubMed Citation Articles by Andreassen, A. Articles by Fodstad, O.

p53 Abnormalities in Different Subtypes of Human Sarcomas¹

Departments of Tumor Biology [Å. A., T. Ø., E. H., V. A. F., O. M., Ø. S. B., Ø. F.], Genetics [A-L. B.], and Pathology [R. H., J. M. N.], Institute for Cancer Research, and Department of Surgical Oncology [J. H.]. The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway

In this report we examined p53 alterations at the DNA, mRNA, and protein levels on tissue from 39 patients with different subtypes of sarcoma. Loss of heterozygosity for the chromosome 17p region was found in 60, 63, and 33% of 10 informative osteosarcomas, 11 malignant fibrous histiocytomas, and 6 leiomyosarcomas, respectively. In addition, 2 of 10 tumors belonging to a heterogeneous group of soft tissue sarcomas showed loss of heterozygosity. Elevated levels of p53 mRNA were found in six tumors, four had a truncated transcript, and in six patients no mRNA was detected. In most cases, elevated transcript levels were accompanied by overexpression of protein as studied by immunohistochemistry, whereas the presence of truncated transcripts was associated with negative immunostaining. Point mutations in exons 5, 7, or 8 of the TP53 gene were detected in seven tumors. Six of these expressed high levels of mRNA and protein, probably reflecting a point mutation in one of the alleles and loss of the other. Three of the mutations have not previously been described. Taken together, p53 abnormalities were found in approximately 65% of the osteosarcomas, malignant fibrous histiocytomas, and lelomyosarcomas examined and in 30% of the other soft tissue tumors. The results indicate that the TP53 gene is involved in the tumorigenesis of several sarcoma subtypes in a higher fraction of cases than was previously recognized.

¹ This work was supported by the Norwegian Cancer Society, The Anders Jahre Fund, and the Blix Legacy.

² To whom requests for reprints should be addressed.

Received 10/26/92. Accepted 12/15/92.

This article has been cited by other articles:

				K. Aogi, A. Woodman, V. Urquidi, D. C. Mangham, D. Tarin, and S. Goodison Telomerase Activity in Soft-Tissue and Bone Sarcomas Clin. Cancer Res., December 1, 2000; 6(12): 4776 - 4781. [Abstract] [Full Text]

				A. Panizo-Santos, I. Sola, F. Vega, E. De Alava, M. D. Lozano, M. A. Idoate, and J. Pardo-Mindin Predicting Metastatic Risk of Gastrointestinal Stromal Tumors: Role of Cell Proliferation and Cell Cycle Regulatory Proteins International Journal of Surgical Pathology, April 1, 2000; 8(2): 133 - 144. [Abstract] [PDF]

				D. F. Kusewitt, T. E. Sherburn, K. B. Miska, G. B. Tafoya, J. M. Gale, and R. D. Miller The p53 tumor suppressor gene of the marsupial Monodelphis domestica: cloning of exons 4–11 and mutations in exons 5–8 in ultraviolet radiation-induced corneal sarcomas Carcinogenesis, June 1, 1999; 20(6): 963 - 968. [Abstract] [Full Text] [PDF]

				L. S. Trukhanova, H.-H. L. Hong, R. C. Sills, A. D. Bowser, B. Gaul, G. A. Boorman, V. S. Turusov, T. R. Devereux, and D. Dixon Predominant p53 G->A Transition Mutation and Enhanced Cell Proliferation in Uterine Sarcomas of CBA Mice Treated with 1,2-Dimethylhydrazine Toxicol Pathol, May 1, 1998; 26(3): 367 - 374. [Abstract] [PDF]

				T. Naka, Y. Iwamoto, N. Shinohara, H. Chuman, and M. Tsuneyoshi p53 Accumulation in Malignant Bone Tumors: An Immunohistochemical Analysis of 217 Cases International Journal of Surgical Pathology, July 1, 1997; 5(1-2): 1 - 9. [Abstract] [PDF]

				L. Jialiang, Y. Guanghua, and L. Gandi Observations on Tumor and Metastatic Suppressor Gene Status in Human Fibrous Neoplasms with Particular Emphasis on p53 and nm23 International Journal of Surgical Pathology, October 1, 1996; 4(2): 87 - 92. [Abstract] [PDF]

				J. R. Goldblum, T. S. Frank, E. L. Poy, and S. W. Weiss p53 Mutations and Tumor Progression in Well-differentiated Liposarcoma and Dermatofibrosarcoma Protuberans International Journal of Surgical Pathology, July 1, 1995; 3(1): 35 - 41. [Abstract] [PDF]